Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.47
-0.1100-0.81%
Volume:912.00K
Turnover:12.26M
Market Cap:2.18B
PE:611.21
High:13.62
Open:13.62
Low:13.18
Close:13.58
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.54
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.05
PE(LYR):303.41

Loading ...

GUIDANCE: (VRTX) Vertex Pharmaceuticals Now Expects 2026 Revenue Range $13.1B-$13.2B, vs. FactSet Est of $13.06B

MT Newswires Live
·
Aug 04

Vertex Inc Fy2026 REV View $827.3 Mln

THOMSON REUTERS
·
Aug 04

Vertex Inc. Q2 Adjusted EPS USD 0.2 VS. Ibes Estimate USD 0.19

THOMSON REUTERS
·
Aug 04

Vertex Inc.: Expects Revenues of $208.0 Million to $211.0 Million for Q3 2026

THOMSON REUTERS
·
Aug 04

Vertex Pharmaceuticals Q2 Adj. EPS $4.73, Inline, Sales $3.334B Beat $3.232B Estimate

Benzinga Earnings
·
Aug 04

Vertex options imply 5.4% move in share price post-earnings

TIPRANKS
·
Aug 04

3 US Stocks Built For Tariff Driven Supply Chain Shifts

Simply Wall St.
·
Aug 03

Vertex Minerals Director Increases Stake via Share Purchase Plan

TIPRANKS
·
Aug 03

Vertex Minerals Director Lifts Stake and Supports Financing via Convertible Loan

TIPRANKS
·
Aug 03

Vertex Minerals Seeks Quotation for 8.58 Million New Shares

TIPRANKS
·
Aug 03

Vertex Minerals bolsters balance sheet with successful share purchase plan

TIPRANKS
·
Aug 03

Vertex Minerals prioritises Reward mine development as funding and recoveries strengthen

TIPRANKS
·
Jul 31

New Vertex Research Signals a Turning Point for Indirect Tax and Compliance: The Rise of Decision-to-Defense

GlobeNewswire
·
Jul 30

Vertex Research Flags Shift to Real-time Indirect Tax Compliance Amid Rising Audit Complexity

Reuters
·
Jul 30

AbCellera and Vertex launch autoimmune T-cell engager partnership

TIPRANKS
·
Jul 30

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 29

Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN), Zoetis (ZTS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 28

Crinetics downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jul 28

Earning Preview: Vertex, Inc. this quarter’s revenue is expected to increase by 9.59%, and institutional views are positive

Earnings Agent
·
Jul 28

Venu Holding Secures $20 Million Bridge Loan Facility with Ryan LLC for Texas Venue Project

Reuters
·
Jul 23